|
|
|
|
|
By Ashok Kumar Dasari, Viatris BLR India | This comprehensive analysis examines lean manufacturing implementation challenges and evidence-based solutions derived from leading pharmaceutical organizations. | |
|
|
|
| The Role Of Cell Culture Media Growth Factors | Article | Corning Life Sciences | Growth factors in cell culture media are essential for cell survival and behavior. Uncover their diverse roles and the science behind choosing the right ones. |
|
|
| Viral Vector Manufacturing Using Tangential Flow Depth Filtration | Poster | By Riaj Mahamud, Ly Truong, Marlon Tannous, et al., Repligen | Address the rising gene therapy demands with an innovative perfusion strategy that significantly boosts cell density and viral vector yields to pave the way for scalable, efficient manufacturing. |
|
|
| Cell Line Development Tools For Rapid Prototyping | Webinar | Sartorius | Discover rapid prototyping tools for cell line development, optimize clone selection, and learn how modern technology reduces process risks to enhance your capabilities with the latest advancements. |
|
|
| Scaling Up For Cell And Gene Therapies | Webinar | PBS Biotech, Inc. | Explore cutting-edge bioreactor strategies and overcome the challenges of large-scale production, including hydrodynamic conditions, media costs, and process reproducibility. |
|
|
| Finding The Right Aseptic Processing Approach | Article | AST | How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions. |
|
|
|
|
| Tackling Encapsidated Host Cell DNA To Improve Quality | Poster | By H. Kewes, T. Bauer, T. Bonifert, J. Drushku, and M. Hussong, Cytiva | Discover a cell line that enhances rAAV production by reducing host cell DNA encapsidation, improving safety and efficiency through genetic modifications that inhibit apoptotic DNA fragmentation. |
|
|
|
|
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
Connect With Cell & Gene: |
|
|
|